Predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation for critical lower limb ischemia

Yamume Tshomba, Daniele Psacharopulo, Serena Frezza, Enrico Maria Marone, Domenico Astore, Roberto Chiesa

Research output: Contribution to journalArticle

Abstract

Background: The aim of this study was to determine predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation (SCS) for critical lower limb ischemia. Methods: We retrospectively analyzed 101 consecutive patients with few meter claudication and nonhealing ulcer who underwent definitive SCS. These patients were selected among 274 SCS patients treated at our center from 1995 to 2012. All presented with non-reconstructable critical leg ischemia (NR-CLI) and underwent supervised exercise therapy, best medical care and regular ulcers standard or advanced medications for at least 1 month before SCS implantation. We measured self-perceived quality of life using the SF-36 questionnaire. Patients with an improved walking distance of at least 30 meters after SCS had significant improvement on SF-36 questionnaire scores. We considered 30 meters as the cut-off for clinically significant improvement in pain-free walking distance, and we defined this value as functional success. Logistic regression was applied to assess baseline and other patient variables as possible predictors of functional success. Results: Neither perioperative mortality nor significant complications were found. At a median follow-up of 69 months (range 1-202 months), mortality, major amputation, and minor amputation were 8.9%, 5.9%, and 6.9%, respectively. Functional clinical success was reported in 25.7% of cases. Independent predictors of functional success at univariate analysis included delay between the onset of the ulcer and SCS (P <0.001) and the pain-free walking distance before SCS (P <0.002). The only predictive factor of functional success at multivariate analysis was the delay between the onset of ulcer and SCS (median delay in patients with and without functional success was 3 and 15 months, respectively). In particular, comparable to pain-free walking distance before SCS, the success rate decreased by 40% for each month elapsed from onset of ulcer to SCS. Conclusions: In our series of patients who underwent SCS, reduced delay between the onset of ulcer and SCS was associated with improved quality of life and walking distance. Larger series are required to confirm these data and to assess clinical implications.

Original languageEnglish
Pages (from-to)628-632
Number of pages5
JournalAnnals of Vascular Surgery
Volume28
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Spinal Cord Stimulation
Lower Extremity
Ischemia
Quality of Life
Ulcer
Walking
Amputation
Exercise Therapy
Mortality
Leg

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation for critical lower limb ischemia. / Tshomba, Yamume; Psacharopulo, Daniele; Frezza, Serena; Marone, Enrico Maria; Astore, Domenico; Chiesa, Roberto.

In: Annals of Vascular Surgery, Vol. 28, No. 3, 2014, p. 628-632.

Research output: Contribution to journalArticle

Tshomba, Yamume ; Psacharopulo, Daniele ; Frezza, Serena ; Marone, Enrico Maria ; Astore, Domenico ; Chiesa, Roberto. / Predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation for critical lower limb ischemia. In: Annals of Vascular Surgery. 2014 ; Vol. 28, No. 3. pp. 628-632.
@article{c6f7cfc6d2944fd59e5f560eab42717e,
title = "Predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation for critical lower limb ischemia",
abstract = "Background: The aim of this study was to determine predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation (SCS) for critical lower limb ischemia. Methods: We retrospectively analyzed 101 consecutive patients with few meter claudication and nonhealing ulcer who underwent definitive SCS. These patients were selected among 274 SCS patients treated at our center from 1995 to 2012. All presented with non-reconstructable critical leg ischemia (NR-CLI) and underwent supervised exercise therapy, best medical care and regular ulcers standard or advanced medications for at least 1 month before SCS implantation. We measured self-perceived quality of life using the SF-36 questionnaire. Patients with an improved walking distance of at least 30 meters after SCS had significant improvement on SF-36 questionnaire scores. We considered 30 meters as the cut-off for clinically significant improvement in pain-free walking distance, and we defined this value as functional success. Logistic regression was applied to assess baseline and other patient variables as possible predictors of functional success. Results: Neither perioperative mortality nor significant complications were found. At a median follow-up of 69 months (range 1-202 months), mortality, major amputation, and minor amputation were 8.9{\%}, 5.9{\%}, and 6.9{\%}, respectively. Functional clinical success was reported in 25.7{\%} of cases. Independent predictors of functional success at univariate analysis included delay between the onset of the ulcer and SCS (P <0.001) and the pain-free walking distance before SCS (P <0.002). The only predictive factor of functional success at multivariate analysis was the delay between the onset of ulcer and SCS (median delay in patients with and without functional success was 3 and 15 months, respectively). In particular, comparable to pain-free walking distance before SCS, the success rate decreased by 40{\%} for each month elapsed from onset of ulcer to SCS. Conclusions: In our series of patients who underwent SCS, reduced delay between the onset of ulcer and SCS was associated with improved quality of life and walking distance. Larger series are required to confirm these data and to assess clinical implications.",
author = "Yamume Tshomba and Daniele Psacharopulo and Serena Frezza and Marone, {Enrico Maria} and Domenico Astore and Roberto Chiesa",
year = "2014",
doi = "10.1016/j.avsg.2013.06.020",
language = "English",
volume = "28",
pages = "628--632",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation for critical lower limb ischemia

AU - Tshomba, Yamume

AU - Psacharopulo, Daniele

AU - Frezza, Serena

AU - Marone, Enrico Maria

AU - Astore, Domenico

AU - Chiesa, Roberto

PY - 2014

Y1 - 2014

N2 - Background: The aim of this study was to determine predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation (SCS) for critical lower limb ischemia. Methods: We retrospectively analyzed 101 consecutive patients with few meter claudication and nonhealing ulcer who underwent definitive SCS. These patients were selected among 274 SCS patients treated at our center from 1995 to 2012. All presented with non-reconstructable critical leg ischemia (NR-CLI) and underwent supervised exercise therapy, best medical care and regular ulcers standard or advanced medications for at least 1 month before SCS implantation. We measured self-perceived quality of life using the SF-36 questionnaire. Patients with an improved walking distance of at least 30 meters after SCS had significant improvement on SF-36 questionnaire scores. We considered 30 meters as the cut-off for clinically significant improvement in pain-free walking distance, and we defined this value as functional success. Logistic regression was applied to assess baseline and other patient variables as possible predictors of functional success. Results: Neither perioperative mortality nor significant complications were found. At a median follow-up of 69 months (range 1-202 months), mortality, major amputation, and minor amputation were 8.9%, 5.9%, and 6.9%, respectively. Functional clinical success was reported in 25.7% of cases. Independent predictors of functional success at univariate analysis included delay between the onset of the ulcer and SCS (P <0.001) and the pain-free walking distance before SCS (P <0.002). The only predictive factor of functional success at multivariate analysis was the delay between the onset of ulcer and SCS (median delay in patients with and without functional success was 3 and 15 months, respectively). In particular, comparable to pain-free walking distance before SCS, the success rate decreased by 40% for each month elapsed from onset of ulcer to SCS. Conclusions: In our series of patients who underwent SCS, reduced delay between the onset of ulcer and SCS was associated with improved quality of life and walking distance. Larger series are required to confirm these data and to assess clinical implications.

AB - Background: The aim of this study was to determine predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation (SCS) for critical lower limb ischemia. Methods: We retrospectively analyzed 101 consecutive patients with few meter claudication and nonhealing ulcer who underwent definitive SCS. These patients were selected among 274 SCS patients treated at our center from 1995 to 2012. All presented with non-reconstructable critical leg ischemia (NR-CLI) and underwent supervised exercise therapy, best medical care and regular ulcers standard or advanced medications for at least 1 month before SCS implantation. We measured self-perceived quality of life using the SF-36 questionnaire. Patients with an improved walking distance of at least 30 meters after SCS had significant improvement on SF-36 questionnaire scores. We considered 30 meters as the cut-off for clinically significant improvement in pain-free walking distance, and we defined this value as functional success. Logistic regression was applied to assess baseline and other patient variables as possible predictors of functional success. Results: Neither perioperative mortality nor significant complications were found. At a median follow-up of 69 months (range 1-202 months), mortality, major amputation, and minor amputation were 8.9%, 5.9%, and 6.9%, respectively. Functional clinical success was reported in 25.7% of cases. Independent predictors of functional success at univariate analysis included delay between the onset of the ulcer and SCS (P <0.001) and the pain-free walking distance before SCS (P <0.002). The only predictive factor of functional success at multivariate analysis was the delay between the onset of ulcer and SCS (median delay in patients with and without functional success was 3 and 15 months, respectively). In particular, comparable to pain-free walking distance before SCS, the success rate decreased by 40% for each month elapsed from onset of ulcer to SCS. Conclusions: In our series of patients who underwent SCS, reduced delay between the onset of ulcer and SCS was associated with improved quality of life and walking distance. Larger series are required to confirm these data and to assess clinical implications.

UR - http://www.scopus.com/inward/record.url?scp=84897031424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897031424&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2013.06.020

DO - 10.1016/j.avsg.2013.06.020

M3 - Article

C2 - 24342447

AN - SCOPUS:84897031424

VL - 28

SP - 628

EP - 632

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

IS - 3

ER -